Scott Weaver from the University of Texas Medical Branch at Galveston was named as a Fellow by the National Academy of Inventors. Weaver will be inducted into the Academy on April 5 during the annual National Academy of Inventors Conference in Washington, D.C.
Weaver, globally recognized for his expertise in mosquito-borne diseases, is the director of the UTMB Institute for Human Infections and Immunity and scientific director of the Galveston National Laboratory. His work has been widely published and he holds nine patents in vaccine development.
He is the chairman of the Global Virus Network’s Zika Task force and co-chairman of the Chikungunya Task Force, which formed to speed the process to creating vaccines and much-needed diagnostic tools for these viruses, as well as to advocate for research efforts. Weaver is also the recipient of the Robert C. Gallo Award for Scientific Excellence from the GVN.
Weaver is the principal investigator of the Centers for Disease Control and Prevention-funded Western Gulf Center of Excellence for Vector-Borne Diseases, a five year, $10 million grant involving seven universities and several county and state public health institutions to improve preparedness and the ability to control vector-borne diseases in Texas and surrounding states.